COMP <GO>
DH vs EGAN // RSI-14 & 200D SMA MOMENTUM
Definitive Healthcare Corp. (Class A) (NASDAQ) VS. eGain Corporation (NASDAQ) • 15-METRIC TALLY: DH 6
— EGAN 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: DH
LAST: $1.12 (0.00%) • MKT CAP: $162.4M
rsi-technicals
63.9
LAST: $5.90 (-0.51%) • MKT CAP: $150.1M
rsi-technicals
57.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DH VS. EGAN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DH | EGAN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 70.10% | +5.80 | DH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 46.70% | -81.70 | EGAN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 22.82% | 3.13% | +19.69 | DH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.00% | -65.00 | EGAN | /operating-margins <GO> |
| Net Profit Margin | -57.50% | 36.50% | -94.00 | EGAN | /net-margins <GO> |
| Revenue Growth (YoY) | -4.20% | -4.70% | +0.50 | DH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | DH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 63.9 | 57.0 | +6.92 | DH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 4.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $162.4M | $150.1M | $12.3M | DH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DH REV | EGAN REV | DH GROSS % | EGAN GROSS % | DH FCF | EGAN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $241.5M | $88.4M | 75.9% | 70.1% | $37.1M | $4.7M |
| FY 2024 | $252.2M | $92.8M | 78.3% | 70.3% | $45.9M | $12.3M |
| FY 2023 | $251.4M | $98.0M | — | — | $41.2M | $4.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DH // BETA —
EGAN // BETA —